Skip to main content

Table 3 Modification effects of therapy on the association between mRS and different exposure variables

From: High-sensitivity C-reactive protein as a better predictor of post-thrombolytic functional outcome in patients with previous antiplatelet therapy

 

ORs (95% CI) P value

Crude

Adjusted

HS.CRP

 Without previous antiplatelet

1.04 (0.99, 1.09) 0.0957

0.96 (0.89, 1.02) 0.2112

 With previous antiplatelet

1.60 (1.09, 2.36) 0.0164

1.34 (0.92, 1.95) 0.1277

 P for interaction

0.0021

0.0101

Infarct volume

 Without previous antiplatelet

1.02 (1.01, 1.03) 0.0008

1.00 (0.99, 1.02) 0.5054

 With previous antiplatelet

1.05 (1.00, 1.12) 0.0728

1.06 (0.99, 1.13) 0.1075

 P for interaction

0.1326

0.0682